Soleno Therapeutics (SLNO)
(Real Time Quote from BATS)
$52.74 USD
-0.81 (-1.51%)
Updated Sep 19, 2024 03:36 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Brokerage Reports
0 items in cart
Soleno Therapeutics, Inc. [SLNO]
Reports for Purchase
Showing records 21 - 34 ( 34 total )
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Healthcare - Part 2 - Which Orphan Companies to See and Why at Our 31st ROTH Conference?
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Healthcare: Kick off EASL by Joining our Battle of the NASH Thrones Investor Conference
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Drugs
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
Making Clinical Progress and Solidifying Regulatory Ground in PWS
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
PWS Research Advances with Natural History Study, Focuses on Hyperphagia
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
We are initiating coverage of Soleno Therapeutics, Inc. with a Buy rating and a $14/share price target.
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Company: Soleno Therapeutics, Inc.
Industry: Medical - Instruments
Termination of Coverage - Analyst(s) Departure
Provider: DAWSON JAMES SECURITIES, INC.